Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R V Srinivas

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
AIDS Research and Human Retroviruses|September 1, 1996
Fluctuating diversity in the HTLV-IIIB virus stock: implications for neutralization and challenge experimentsT D Lockey, K S Slobod, S D Rencher, et al.
The Journal of Biological Chemistry|October 25, 1993
Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteinsS K Srinivas, R V Srinivas, G M Anantharamaiah, et al.
Vaccine|April 9, 1999
A novel vaccine regimen utilizing DNA, vaccinia virus and protein immunizations for HIV-1 envelope presentationT E Caver, T D Lockey, R V Srinivas, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1994
Enzymatic assay for measurement of zidovudine triphosphate in peripheral blood mononuclear cellsB L Robbins, J Rodman, C McDonald, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1993
Metabolism and in vitro antiretroviral activities of bis(pivaloyloxymethyl) prodrugs of acyclic nucleoside phosphonatesR V Srinivas, B L Robbins, M C Connelly, et al.
Virology|May 1, 1990
Antiviral effects of apolipoprotein A-I and its synthetic amphipathic peptide analogsR V Srinivas, B Birkedal, R J Owens, et al.
The Journal of Clinical Investigation|October 1, 1990
Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formationB J Owens, G M Anantharamaiah, J B Kahlon, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1997
In vitro induction of human immunodeficiency virus type 1 variants resistant to 2'-beta-Fluoro-2',3'-dideoxyadenosineM Tanaka, R V Srinivas, T Ueno, et al.
Journal of the National Cancer Institute|March 1, 1987
Monoclonal IgM antibodies that inhibit primary Moloney murine sarcoma growthE W Lamon, T J Powell, A S Walia, et al.
Nature Medicine|September 2, 1999
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugsJ D Schuetz, M C Connelly, D Sun, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
AIDS Research and Human Retroviruses|September 1, 1996
Fluctuating diversity in the HTLV-IIIB virus stock: implications for neutralization and challenge experimentsT D Lockey, K S Slobod, S D Rencher, et al.
The Journal of Biological Chemistry|October 25, 1993
Cytosolic domain of the human immunodeficiency virus envelope glycoproteins binds to calmodulin and inhibits calmodulin-regulated proteinsS K Srinivas, R V Srinivas, G M Anantharamaiah, et al.
Vaccine|April 9, 1999
A novel vaccine regimen utilizing DNA, vaccinia virus and protein immunizations for HIV-1 envelope presentationT E Caver, T D Lockey, R V Srinivas, et al.
Antimicrobial Agents and Chemotherapy|January 1, 1994
Enzymatic assay for measurement of zidovudine triphosphate in peripheral blood mononuclear cellsB L Robbins, J Rodman, C McDonald, et al.
Antimicrobial Agents and Chemotherapy|October 1, 1993
Metabolism and in vitro antiretroviral activities of bis(pivaloyloxymethyl) prodrugs of acyclic nucleoside phosphonatesR V Srinivas, B L Robbins, M C Connelly, et al.
Virology|May 1, 1990
Antiviral effects of apolipoprotein A-I and its synthetic amphipathic peptide analogsR V Srinivas, B Birkedal, R J Owens, et al.
The Journal of Clinical Investigation|October 1, 1990
Apolipoprotein A-I and its amphipathic helix peptide analogues inhibit human immunodeficiency virus-induced syncytium formationB J Owens, G M Anantharamaiah, J B Kahlon, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1997
In vitro induction of human immunodeficiency virus type 1 variants resistant to 2'-beta-Fluoro-2',3'-dideoxyadenosineM Tanaka, R V Srinivas, T Ueno, et al.
Journal of the National Cancer Institute|March 1, 1987
Monoclonal IgM antibodies that inhibit primary Moloney murine sarcoma growthE W Lamon, T J Powell, A S Walia, et al.
Nature Medicine|September 2, 1999
MRP4: A previously unidentified factor in resistance to nucleoside-based antiviral drugsJ D Schuetz, M C Connelly, D Sun, et al.
Pageof 6